Security key
28617K101
Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (ELDN)
CUSIP: 28617K101
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock, $0.001 par value
- Shares outstanding
- 78,762,953
- Total 13F shares
- 38,448,901
- Share change
- -30,655
- Total reported value
- $130,340,726
- Put/Call ratio
- 634%
- Price per share
- $3.39
- Number of holders
- 83
- Value change
- -$2,283,033
- Number of buys
- 35
- Number of sells
- 31
Report period
Q1 2025
Institutions
83
Top holders
10
ELDN full security history
Newer quarter: Q2 2025
Previous quarter: Q4 2024
Eledon Pharmaceuticals, Inc. SEC filings
Eledon Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 28617K101
Recent filing periods:
Top shareholders of ELDN - Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13D/G
|
— |
5%
|
3,137,553
|
$10,259,798 | $0 | 31 Dec 2024 | |
| Frazier Life Sciences Public Fund, L.P. |
13D/G
|
James N. Topper |
2%
|
1,176,735
|
$3,847,923 | $0 | 31 Dec 2024 | |
| BVF INC/IL |
13F
|
Company |
8%
|
6,293,282
|
$25,928,322 | — | 31 Dec 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
4.5%
|
3,566,338
|
$14,693,313 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.7%
|
2,894,639
|
$11,925,913 | — | 31 Dec 2024 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
3.2%
|
2,551,619
|
$10,512,670 | — | 31 Dec 2024 | |
| First Light Asset Management, LLC |
13F
|
Company |
3%
|
2,328,768
|
$9,594,524 | — | 31 Dec 2024 | |
| Blue Owl Capital Holdings LP |
13F
|
Company |
2.5%
|
1,959,912
|
$8,074,837 | — | 31 Dec 2024 | |
| Woodline Partners LP |
13F
|
Company |
2.1%
|
1,671,822
|
$6,887,907 | — | 31 Dec 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
1.9%
|
1,515,750
|
$6,244,889 | — | 31 Dec 2024 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
1.6%
|
1,264,919
|
$5,211,466 | — | 31 Dec 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
1.5%
|
1,176,735
|
$4,848,148 | — | 31 Dec 2024 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
1.5%
|
1,147,946
|
$4,729,538 | — | 31 Dec 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
1.4%
|
1,126,637
|
$4,641,745 | — | 31 Dec 2024 | |
| AWM Investment Company, Inc. |
13F
|
Company |
1.4%
|
1,100,473
|
$4,533,949 | — | 31 Dec 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.4%
|
1,095,000
|
$4,511,400 | — | 31 Dec 2024 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
1.2%
|
933,475
|
$3,845,917 | — | 31 Dec 2024 | |
| Sanofi |
13F
|
Company |
1%
|
814,980
|
$3,357,718 | — | 31 Dec 2024 | |
| Zimmer Partners, LP |
13F
|
Company |
0.95%
|
750,000
|
$3,090,000 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.84%
|
663,101
|
$2,733,011 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
0.78%
|
617,624
|
$2,544,612 | — | 31 Dec 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.43%
|
341,923
|
$1,408,723 | — | 31 Dec 2024 | |
| Velan Capital Investment Management LP |
13F
|
Company |
0.41%
|
323,973
|
$1,334,769 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.4%
|
318,581
|
$1,312,553 | — | 31 Dec 2024 | |
| CM Management, LLC |
13F
|
Company |
0.35%
|
275,000
|
$1,133,000 | — | 31 Dec 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.34%
|
269,025
|
$1,108,383 | — | 31 Dec 2024 | |
| Exome Asset Management LLC |
13F
|
Company |
0.33%
|
256,373
|
$1,056,257 | — | 31 Dec 2024 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.3%
|
235,750
|
$971,290 | — | 31 Dec 2024 | |
| Inspire Investing, LLC |
13F
|
Company |
0.25%
|
194,688
|
$802,115 | — | 31 Dec 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.24%
|
189,870
|
$782,264 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.24%
|
187,001
|
$770,444 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.22%
|
174,506
|
$718,965 | — | 31 Dec 2024 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.2%
|
154,960
|
$638,435 | — | 31 Dec 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.19%
|
147,173
|
$606,353 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.18%
|
144,845
|
$596,761 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.16%
|
126,885
|
$522,766 | — | 31 Dec 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.16%
|
122,275
|
$503,773 | — | 31 Dec 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.16%
|
122,141
|
$503,221 | — | 31 Dec 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.15%
|
118,861
|
$489,707 | — | 31 Dec 2024 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.14%
|
109,555
|
$451,367 | — | 31 Dec 2024 | |
| Allostery Investments LP |
13F
|
Company |
0.13%
|
100,000
|
$412,000 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.12%
|
95,142
|
$391,985 | — | 31 Dec 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.1%
|
80,431
|
$331,376 | — | 31 Dec 2024 | |
| DIADEMA PARTNERS LP |
13F
|
Company |
0.1%
|
75,794
|
$312,271 | — | 31 Dec 2024 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.09%
|
74,576
|
$307,253 | — | 31 Dec 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.09%
|
70,000
|
$288,400 | — | 31 Dec 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.08%
|
66,900
|
$275,628 | — | 31 Dec 2024 | |
| OMERS ADMINISTRATION Corp |
13F
|
Company |
0.08%
|
62,800
|
$258,736 | — | 31 Dec 2024 | |
| JMAC ENTERPRISES LLC |
13F
|
Company |
0.07%
|
58,041
|
$239,129 | — | 31 Dec 2024 | |
| INGALLS & SNYDER LLC |
13F
|
Company |
0.07%
|
51,849
|
$214,000 | — | 31 Dec 2024 |
Institutional Holders of Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (ELDN) as of Q1 2025
As of 31 Mar 2025,
Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (ELDN) was held by
83 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,448,901 shares.
The largest 10 holders included
BVF INC/IL, RA CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, First Light Asset Management, LLC, SPHERA FUNDS MANAGEMENT LTD., Blue Owl Capital Holdings LP, Woodline Partners LP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Schonfeld Strategic Advisors LLC, and Ensign Peak Advisors, Inc.
This page lists
83
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
75
Q1 2025 holders
83
Holder diff
8
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.